Bionxt Solutions Inc. (BNXT.CN)
0.5800 +0.0100 (+1.75%) 12:25 ET [CNSX]
0.5700 x 2000 0.5800 x 10000
Realtime by (Cboe BZX)
0.5700 x 2000 0.5800 x 10000
Realtime - - (-) -
for Mon, Mar 17th, 2025
Fiscal Year End Date: 12/31
(Values in thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 372 | 297 | 286 | 346 | 208 |
Cost of Goods | 0 | 102 | 87 | N/A | N/A |
Gross Profit | 372 | 196 | 199 | N/A | N/A |
Operating Expenses | 6,759 | 6,241 | 16,510 | 15,149 | 7,324 |
Operating Income | -6,387 | -6,045 | -16,310 | -14,804 | -7,116 |
Interest Expense | 1,043 | 1,143 | 732 | 297 | 105 |
Other Income | -293 | -5,682 | -3,706 | -2,146 | -492 |
Pre-tax Income | -7,723 | -12,870 | -20,748 | -17,247 | -7,714 |
Income Tax | 0 | -494 | -111 | -357 | -45 |
Net Income Continuous | -7,723 | -12,376 | -20,637 | -16,890 | -7,669 |
Net Income | $-7,723 | $-12,376 | $-20,637 | $-16,890 | $-7,669 |
EPS Basic Total Ops | -0.08 | -0.15 | -0.29 | -0.30 | -0.17 |
EPS Basic Continuous Ops | -0.08 | -0.15 | -0.29 | -0.30 | -0.17 |
EPS Diluted Total Ops | -0.08 | -0.15 | -0.29 | -0.30 | -0.17 |
EPS Diluted Continuous Ops | -0.08 | -0.15 | -0.29 | -0.30 | -0.17 |
EBITDA(a) | $-6,485 | $-11,512 | $-19,193 | $-16,054 | $-6,663 |